{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:44:46Z","timestamp":1773290686833,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.amepre.2016.12.016","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T21:46:44Z","timestamp":1486072004000},"page":"625-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hepatitis C Antibody Testing in a Commercially Insured Population, 2005\u20132014"],"prefix":"10.1016","volume":"52","author":[{"given":"Cheryl J.","family":"Isenhour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan H.","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia J.","family":"Vellozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"Edlin","year":"2015","journal-title":"Hepatology"},{"issue":"RR-4","key":"10.1016\/j.amepre.2016.12.016_bib2","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amepre.2016.12.016_bib3","unstructured":"CDC Viral Hepatitis Surveillance United States, 2013. www.cdc.gov\/hepatitis\/statistics\/2013surveillance\/pdfs\/2013hepsurveillancerpt.pdf. Accessed November 9, 2015."},{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.amepre.2016.12.016_bib5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.amepre.2016.12.016_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003-2013","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2016.12.016_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0748-8","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits","volume":"15","author":"Smith-Palmer","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.amepre.2016.12.016_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s12325-015-0258-5","article-title":"Early view of the effectiveness of new direct-acting antiviral (DAA) regimens in patients with hepatitis C Virus (HCV)","volume":"32","author":"Walker","year":"2015","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.amepre.2016.12.016_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.25556","article-title":"Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008","volume":"55","author":"Denniston","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amepre.2016.12.016_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/003335490612100611","article-title":"Self-reported hepatitis C virus antibody status and risk behavior in young injectors","volume":"121","author":"Hagan","year":"2006","journal-title":"Public Health Rep"},{"issue":"6","key":"10.1016\/j.amepre.2016.12.016_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10903-016-0350-1","article-title":"Awareness of hepatitis C virus seropositivity and chronic infection in the Hispanic community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"18","author":"Kuniholm","year":"2016","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.amepre.2016.12.016_bib12","unstructured":"American Association for the Study of Liver Disease. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. HCV Testing and Linkage to Care. www.hcvguidelines.org\/full-report\/hcv-testing-and-linkage-care. Accessed November 10, 2015."},{"issue":"RR-19","key":"10.1016\/j.amepre.2016.12.016_bib13","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"RR-1","key":"10.1016\/j.amepre.2016.12.016_bib14","first-page":"1","article-title":"Prevention and control of infections with hepatitis viruses in correctional settings","volume":"52","author":"Weinbaum","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.amepre.2016.12.016_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-158-2-201301150-00574","article-title":"Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amepre.2016.12.016_bib16","unstructured":"U.S. Preventive Services Task Force. Hepatitis C: Screening Recommendations Summary. www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/hepatitis-c-screening. Accessed November 16, 2015."},{"issue":"4","key":"10.1016\/j.amepre.2016.12.016_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-156-4-201202210-00378","article-title":"The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings","volume":"156","author":"Rein","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2016.12.016_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.26304","article-title":"The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States","volume":"58","author":"McEwan","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/hep.25510","article-title":"Economic model of a birth cohort screening program for hepatitis C virus","volume":"55","author":"McGarry","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.amepre.2016.12.016_bib20","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2105\/AJPH.2013.301211","article-title":"Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010","volume":"103","author":"Mahajan","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2016.12.016_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7556\/jaoa.2016.001","article-title":"Hepatitis C virus infection screening within community health centers","volume":"116","author":"Cook","year":"2016","journal-title":"J Am Osteopath Assoc"},{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib22","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amepre.2014.12.002","article-title":"Prevalence of hepatitis C virus testing in cohorts born between 1945 and 1965 in the U.S","volume":"48","author":"Jemal","year":"2015","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib23","doi-asserted-by":"crossref","first-page":"e97317","DOI":"10.1371\/journal.pone.0097317","article-title":"The hepatitis C cascade of care: identifying priorities to improve clinical outcomes","volume":"9","author":"Linas","year":"2014","journal-title":"PLoS One"},{"issue":"449","key":"10.1016\/j.amepre.2016.12.016_bib24","first-page":"1","article-title":"Hepatitis C virus screening practices and seropositivity among U.S. veterans born during 1945-1965","volume":"7","author":"Cartwright","year":"2014","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.amepre.2016.12.016_bib25","first-page":"250","article-title":"Population-based hepatitis C surveillance and treatment in a national managed care organization","volume":"10","author":"Shatin","year":"2004","journal-title":"Am J Manag Care"},{"issue":"8","key":"10.1016\/j.amepre.2016.12.016_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/cid\/cis616","article-title":"Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence","volume":"55","author":"Spradling","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amepre.2016.12.016_bib27","first-page":"548","article-title":"HCV screening practices and prevalence in an MCO, 2000-2007","volume":"17","author":"Roblin","year":"2011","journal-title":"Am J Manag Care"},{"issue":"10","key":"10.1016\/j.amepre.2016.12.016_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1089\/jwh.2006.15.1205","article-title":"Gender differences across race\/ethnicity in use of health care among Medicare-aged Americans","volume":"15","author":"Song","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"10.1016\/j.amepre.2016.12.016_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jwh.2011.2876","article-title":"Gender differences in utilization of preventive care services in the United States","volume":"21","author":"Vaidya","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"issue":"17","key":"10.1016\/j.amepre.2016.12.016_bib30","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2016.12.016_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/pgm.2014.07.2783","article-title":"The economic burden of diagnosed opioid abuse among commercially insured individuals","volume":"126","author":"Rice","year":"2014","journal-title":"Postgrad Med"},{"issue":"3","key":"10.1016\/j.amepre.2016.12.016_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5055\/jom.2013.0158","article-title":"Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States","volume":"9","author":"Roland","year":"2013","journal-title":"J Opioid Manag"},{"issue":"5","key":"10.1016\/j.amepre.2016.12.016_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2893.2001.00310.x","article-title":"Management of hepatitis C patients by primary care physicians in the USA: results of a national survey","volume":"8","author":"Shehab","year":"2001","journal-title":"J Viral Hepat"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716306973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716306973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T05:01:33Z","timestamp":1538024493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379716306973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0749379716306973"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2016.12.016","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Antibody Testing in a Commercially Insured Population, 2005\u20132014","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine","name":"copyright","label":"Copyright"}]}}